Status:
COMPLETED
Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsia
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Antiphospholipid Antibody Syndrome in Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
Study based on data concerning the first pregnancy treated and followed up after the diagnosis of oAPS in the NOH-APS cohort, according to clinical results already published; and on a thematic library...
Eligibility Criteria
Inclusion
- Presence of frozen plasma samples from the positive pregnancy test blood sample.
- Adult patients, included in the NOH-APS cohort, who have successfully initiated a new pregnancy after diagnosis of oAPS.
Exclusion
- Absence of frozen plasma sample from the blood sample from the positive pregnancy test.
- Patient who objected to the use of their data.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
513 Patients enrolled
Trial Details
Trial ID
NCT04319341
Start Date
April 1 2020
End Date
December 31 2020
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes - Hôpital Universitaire Carémea
Nîmes, France, 30029